The idea that these mutations reflect myelodysplasia is reflected in the WHO-classification and the International-Consensus-Classification which – with the exemption of RUNX1 in the WHO-classification – also see these mutations as defining AML with myelodysplasia-related genetic changes [41, 42]. Here, RUNX1 is linked to acute myeloid leukemia.